Suchergebnisse - "Buelow, Daelynn R"

PubPharm (34)

1

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia : Alliance for Clinical Trials in Oncology study

enthalten in: Blood advances | 2023

von Bhatnagar, B. | Kohlschmidt, J. | Orwick, S. | +14

2

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

enthalten in: Cancers | 2022

von Eisenmann, E. | Stromatt, J. | Fobare, S. | +10

3

BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors

enthalten in: Blood advances | 2022

von Buelow, D. | Bhatnagar, B. | Orwick, S. | +7

4

Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Inaba, H. | van Oosterwijk, J. | Panetta, J. | +9

5

Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia

enthalten in: Blood advances | 2021

von Zavorka Thomas, M. | Jeon, J. | Talebi, Z. | +6

6

Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD-Positive AML

enthalten in: Molecular cancer therapeutics | 2021

von Zavorka Thomas, M. | Lu, X. | Talebi, Z. | +15

7

DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia

enthalten in: Clinical and translational science | 2021

von Buelow, D. | Anderson, J. | Pounds, S. | +7

8

TP-0903 is active in models of drug-resistant acute myeloid leukemia

enthalten in: JCI insight | 2020

von Jeon, J. | Buelow, D. | Garrison, D. | +17

9

Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML

enthalten in: Investigational new drugs | 2020

von Jeon, J. | Zhao, Q. | Buelow, D. | +12

10

Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML

enthalten in: Clinical and translational science | 2019

von Buelow, D. | Pounds, S. | Wang, Y. | +16